Orthopedic bone cement market is anticipated to value over US$ 1.4 billion by the end of 2026 and registering a CAGR of over 5.2% during the forecast period, 2019 to 2026.
This market finds its application in orthopedic surgeries or knee replacements and aids in the medical world. In these surgeries, bone cement is primarily used. Known widely as polymethylmethacrylate (PMMA) and is medically used for implants in various orthopedic, dental, and trauma surgeries. Bone cement has no adhesive properties of its own; however, it relies on close mechanical interlock between the irregular bone surface and the prosthesis. Calcium phosphate cement (CPC) and glass polyalkenoate (ionomer) cement (GPC) are commercial names of bone cement. CPC is used primarily in cranial and maxillofacial surgeries due to its low mechanical strength and is sustainable-bioabsorbable and biocompatible. The use of various bone cement has expanded over the past centuries. Extensive research has been done to expand clinical applications and reduce the adverse effects associated with its use in surgery thus will positively affect the trade.
Rising cases of osteoporosis is a major factor driving the global bone cement market. Increased incidences of periodontics among the youth, as well as among the geriatric population are major factors that are anticipated to drive the bone cement market. An increasing number of local and global players entering the market with innovations such as antibiotic-impregnated bone cement has significantly increased its use and expanded into the domains pathological fractures and general prosthetic fixation.
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=209&page=requestsample
Orthopedic Bone Cement Market: Restraints
+ Preference for bone graft over bone cement products
+ Medical complications
Orthopedic Bone Cement Market Segmentation
By Product Type
+ Low Viscosity Cements
+ Medium Viscosity Cements
+ High Viscosity Cements
+ Antibiotic Cements
By End User
+ Hospitals
+ Orthopedic Clinics
+ Outpatient Centres
By Region
+ North America
+ Latin America
+ Europe
+ Asia Pacific
+ Rest of the World
North America is estimated to enjoy a major market share during the forecast period. Furthermore, the increased occurrence of arthritis it is and periodontal diseases, especially in developing countries such as China and India has led to an increase in demand for surgeries. Knee surgeries and general prosthetic fixation have increased in the Asia Pacific. This is anticipated to fuel the demand for cost-effective surgeries, which is projected to drive the bone cement market in the Asia Pacific during the forecast period.
Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=209&page=askfordiscount

Competitive Landscape:
+ Tier 1 players- Established companies in the market with a major market share
+ Tier 2 players -Emerging players which are growing rapidly
+ New Entrants
+ Key market players operating in the global bone cement market are Heraeus Holding, DJO Global, Stryker, Zimmer Biomet, Arthrex, Inc., Tecres SpA, Heraeus Holding, OsteoRemedies, LLC, TEKNIMED, Smith & Nephew, 3M, Exactech, Inc., DePuy Synthes Companies, Orthofix International N.V., and BSN medical GmbH. These firms are majorly focused on various growth strategies such as new product launches, partnerships and collaborations, and acquisitions to establish a strong foothold in the global market. For instance, in January 2018, Tecres S.p.A announced the launch of Vancogenx HV. Vancogenx HV is a high viscosity bone cement, which is preloaded with gentamicin and vancomycin. The launch of the product has widened the product offering of the company.
FutureWise Key Takeaways
+ Growth prospects
+ SWOT analysis
+ Key trends
+ Key data-points affecting market growth
Objectives of the Study:
+ To provide with an exhaustive analysis on the global orthopedic bone cement market by product type, by end-user, and by region
+ To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
+ To evaluate and forecast micro-markets and the overall market
+ To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
+ To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
+ Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Table of Contents
1.1. Introduction
1.1.1.1. Scope and Objective
1.1.1.2. Assumptions and Acronyms
1.1.1.3. Forecast Factors
1.1.1.4. Research Methodology
1.2. Executive Summary
1.2.1.1. Industry Cluster Analysis
1.2.1.2. Competition Matrix
1.2.1.3. Strategies Recommendations
1.3. Market Definition
1.3.1.1. Report Scope (Inclusions & Exclusions)
1.3.1.2. Market Segmentation
1.4. Global s Market Overview
1.4.1.1. Global Orthopedic Bone Cement Market Revenue (USD Mn)
1.5. Key Inclusions
1.5.1.1. Porter’s Five Force analysis
1.5.1.2. Market Dynamics
1.5.1.3. Industry Trends
1.5.1.4. Regulatory Guidelines
1.5.1.5. Opportunities in Orthopedic Bone Cement
1.6. Competition Dynamics
1.6.1.1. Company Share Analysis (2018)
1.6.1.2. Top 10 Product Pricing by Region
1.7. Global Orthopedic Bone Cement Market Revenue (USD Mn), 2018-2026 by Product Type
1.7.1.1. Key Market Findings
1.7.1.2. Long Term ROI Segments
1.7.1.3. Revenue Opportunity Influencing Factors
1.7.1.4. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
1.7.1.4.1.1. Low Viscosity Cements
1.7.1.4.1.2. Medium Viscosity Cements
1.7.1.4.1.3. High Viscosity Cements
1.7.1.4.1.4. Antibiotic Cements
1.8. Global Orthopedic Bone Cement Market Revenue (USD Mn), 2018-2026 by End User
1.8.1.1. Key Market Findings
1.8.1.2. Long Term ROI Segments
1.8.1.3. Revenue Opportunity Influencing Factors
1.8.1.4. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.8.1.4.1.1. Hospitals
1.8.1.4.1.2. Orthopedic Clinics
1.8.1.4.1.3. Outpatient Centres
1.9. Global Orthopedic Bone Cement Market Revenue (USD Mn), 2018-2026 by Region
1.9.1.1. Key Market Findings
1.9.1.2. Long Term ROI Segments
1.9.1.3. Revenue Opportunity Influencing Factors
1.9.1.4. Market Revenue (USD Mn) Assessment and Forecast by Region,2026
1.9.1.4.1.1. North America
1.9.1.4.1.2. Latin America
1.9.1.4.1.3. Europe
1.9.1.4.1.4. Asia Pacific
1.9.1.4.1.5. Rest of world
1.10. North America Orthopedic Bone Cement Market Revenue (US$ Mn), 2018-2026
1.10.1.1. Key Market Findings
1.10.1.2. Long Term ROI Segments
1.10.1.3. Revenue Opportunity Influencing Factors
1.10.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.10.1.4.1.1. US
1.10.1.4.1.2. Canada
1.10.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
1.10.1.5.1.1. Low Viscosity Cements
1.10.1.5.1.2. Medium Viscosity Cements
1.10.1.5.1.3. High Viscosity Cements
1.10.1.5.1.4. Antibiotic Cements
1.10.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.10.1.6.1.1. Hospitals
1.10.1.6.1.2. Orthopedic Clinics
1.10.1.6.1.3. Outpatient Centres
1.11. Latin America Orthopedic Bone Cement Market Revenue (US$ Mn), 2018-2026
1.11.1.1. Key Market Findings
1.11.1.2. Long Term ROI Segments
1.11.1.3. Revenue Opportunity Influencing Factors
1.11.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.11.1.4.1.1. Brazil
1.11.1.4.1.2. Mexico
1.11.1.4.1.3. Argentina
1.11.1.4.1.4. Rest of Latin America
1.11.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
1.11.1.5.1.1. Low Viscosity Cements
1.11.1.5.1.2. Medium Viscosity Cements
1.11.1.5.1.3. High Viscosity Cements
1.11.1.5.1.4. Antibiotic Cements
1.11.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.11.1.6.1.1. Hospitals
1.11.1.6.1.1.1. Orthopedic Clinics
1.11.1.6.1.1.2. Outpatient Centres
1.12. Europe America Orthopedic Bone Cement Market Revenue (US$ Mn), 2018-2026
1.12.1.1. Key Market Findings
1.12.1.2. Long Term ROI Segments
1.12.1.3. Revenue Opportunity Influencing Factors
1.12.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.12.1.4.1.1. Germany
1.12.1.4.1.2. France
1.12.1.4.1.3. Spain
1.12.1.4.1.4. UK
1.12.1.4.1.5. Russia
1.12.1.4.1.6. Poland
1.12.1.4.1.7. Rest of Europe
1.12.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
1.12.1.5.1.1. Low Viscosity Cements
1.12.1.5.1.2. Medium Viscosity Cements
1.12.1.5.1.2.1. High Viscosity Cements
1.12.1.5.1.2.2. Antibiotic Cements
1.12.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.12.1.6.1.1.1. Hospitals
1.12.1.6.1.1.2. Orthopedic Clinics
1.12.1.6.1.1.3. Outpatient Centres
1.13. Asia Pacific America Orthopedic Bone Cement Market Revenue (US$ Mn), 2018-2026
1.13.1.1. Key Market Findings
1.13.1.2. Long Term ROI Segments
1.13.1.3. Revenue Opportunity Influencing Factors
1.13.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.13.1.4.1.1. Emerging Asia
1.13.1.4.1.1.1.1. China
1.13.1.4.1.1.1.2. India
1.13.1.4.1.1.1.3. ASEAN-5
1.13.1.4.1.1.1.4. Rest of Emerging Asia
1.13.1.4.1.2. Japan
1.13.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
1.13.1.5.1.1. Low Viscosity Cements
1.13.1.5.1.2. Medium Viscosity Cements
1.13.1.5.1.3. High Viscosity Cements
1.13.1.5.1.4. Antibiotic Cements
1.13.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.13.1.6.1.1. Hospitals
1.13.1.6.1.2. Orthopedic Clinics
1.13.1.6.1.3. Outpatient Centres
1.14. Rest of World America Orthopedic Bone Cement Market Revenue (US$ Mn), 2018-2026
1.14.1.1. Key Market Findings
1.14.1.2. Long Term ROI Segments
1.14.1.3. Revenue Opportunity Influencing Factors
1.14.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.14.1.4.1.1. Middle East
1.14.1.4.1.2. South Africa
1.14.1.4.1.3. North Africa
1.14.1.4.1.4. Rest of World
1.14.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product Type, 2018-2026
1.14.1.5.1.1. Low Viscosity Cements
1.14.1.5.1.2. Medium Viscosity Cements
1.14.1.5.1.3. High Viscosity Cements
1.14.1.5.1.4. Antibiotic Cements
1.14.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.14.1.6.1.1. Hospitals
1.14.1.6.1.1.1. Orthopedic Clinics
1.14.1.6.1.1.2. Outpatient Centres
1.15. Company Profiles
1.15.1.1. Competition Landscape
1.15.1.2. Global Company Share (USD Mn) Overview, 2018
1.15.1.3. Company Profiles
1.15.1.3.1.1. Stryker Corporation
1.15.1.3.1.1.1.1. Corporate Overview
1.15.1.3.1.1.1.2. Financial Performance
1.15.1.3.1.1.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.1.1.4. Company Strategy & Channel Management
1.15.1.3.1.2. DJO Global
1.15.1.3.1.2.1.1. Corporate Overview
1.15.1.3.1.2.1.2. Financial Performance
1.15.1.3.1.2.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.2.1.4. Company Strategy & Channel Management
1.15.1.3.1.3. Smith & Nephew
1.15.1.3.1.3.1.1. Corporate Overview
1.15.1.3.1.3.1.2. Financial Performance
1.15.1.3.1.3.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.3.1.4. Company Strategy & Channel Management
1.15.1.3.1.4. Teknimed
1.15.1.3.1.4.1.1. Corporate Overview
1.15.1.3.1.4.1.2. Financial Performance
1.15.1.3.1.4.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.4.1.4. Company Strategy & Channel Management
1.15.1.3.1.5. Zimmer Biomet
1.15.1.3.1.5.1.1. Corporate Overview
1.15.1.3.1.5.1.2. Financial Performance
1.15.1.3.1.5.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.5.1.4. Company Strategy & Channel Management
1.15.1.3.1.6. Synimed
1.15.1.3.1.6.1.1. Corporate Overview
1.15.1.3.1.6.1.2. Financial Performance
1.15.1.3.1.6.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.6.1.4. Company Strategy & Channel Management
1.15.1.3.1.7. Depuy Synthes
1.15.1.3.1.7.1.1. Corporate Overview
1.15.1.3.1.7.1.2. Financial Performance
1.15.1.3.1.7.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.7.1.4. Company Strategy & Channel Management
1.15.1.3.1.8. Exactech
1.15.1.3.1.8.1.1. Corporate Overview
1.15.1.3.1.8.1.2. Financial Performance
1.15.1.3.1.8.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.8.1.4. Company Strategy & Channel Management
1.15.1.3.1.9. Groupe Lepine
1.15.1.3.1.9.1.1. Corporate Overview
1.15.1.3.1.9.1.2. Financial Performance
1.15.1.3.1.9.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.9.1.4. Company Strategy & Channel Management
1.15.1.3.1.9.2. Elite Surgical
1.15.1.3.1.9.2.1. Corporate Overview
1.15.1.3.1.9.2.2. Financial Performance
1.15.1.3.1.9.2.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.9.2.4. Company Strategy & Channel Management
1.16. Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]

About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com